Back to results
US 2014/0274878 A1Published application
Aminothiazoles and their uses
AssigneeNovartis AG
InventorsSimon Bushell, Matthew J. Lamarche, Jennifer Leeds, Lewis Whitehead
Life of this patent
Estimating the term…
Abstract
The present application describes organic compounds of Formula (I) and pharmaceutical compositions thereof, and their use for the treatment, prevention and/or amelioration of diseases, particularly bacterial infections.
Claims21
A compound of the formula I:
- or a pharmaceutically acceptable salt thereof, including the pyridine N-oxide thereof,
- wherein:
- R1 is —Z—CO2H and -A-Z—CO2H;
- R1a is hydrogen, —Z—CO2H, and -A-Z—CO2H, wherein if R1a is hydrogen, then the Z residue of R1 is substituted by at least two CO2H groups;
- or
- R1 and R1a, taken in combination, form a saturated, partially unsaturated or aromatic heterocycle having 4 to 7 ring atoms and having 0-3 additional ring heteroatoms selected from N, O and S, wherein the heterocycle is substituted by at least two residues independently selected from CO2H, —Z—CO2H, and -A-Z—CO2H;
- A is independently selected at each occurrence from the group consisting of a —C(O)—, —C(O)O—, —C(O)N(R8a)—, —S(O)2—, —S(O)—, —C(H)═N—, —S(O)2N(R8a)—, and —S(O)N(R8a)—;
- Z is C1-C10alkylene, C3-C8cycloalkylene, C3-C8heterocycloalkylene, phenylene, or 5-6 membered heteroarylene, each of which is optionally substituted with one or more groups independently selected from C1-C4alkyl, C1-C4alkoxy, hydroxy, amino, mono- and di-C1-C6alkylamino, C(O)OH, or halogen;
- R2a is selected from the group consisting of H, substituted or unsubstituted alkyl, OH, OR4a, OC(O)R4a, OC(O)N(R8a)2 and N(R8a)2;
- R2b is selected from the group consisting of absent, H and alkyl, or R2a and R2b may together form ═O or ═NH;
- R3 an R12 are each, independently, selected from the group consisting of H, halogen, OR4b, -A-J, and N(R8a)2;
- R4a is selected from the group consisting of H, and alkyl;
- R4b is selected from the group consisting of alkyl and —(CH2—CH2—O—)n—R9, wherein n is an integer of 1-500, 1,000, 2,000, 3,000, 4,000, 5,000, 10,000, 20,000, 30,000, 40,000, 50,000, or 60,000 or is a mean of a plurality of integers having a value of 1-500, 1,000, 2,000, 3,000, 4,000, 5,000, 10,000, 20,000, 30,000, 40,000, 50,000, or 60,000;
- R5 is selected from the group consisting of H, alkyl, and R4b;
- J is selected from the group consisting of H, F, O-alkyl, N(R8a)2, N+(R8a)3, N(R8a)C(O)alkyl, CO2H, C(═O)N(R8a)2, CO2-alkyl, P(O)(OH)2, P(O)(O-alkyl)2, and a substituted nitrogen-containing heterocycle;
- R8a is absent, or selected from the group consisting of H, -(alkyl)-, -(cycloalkyl)-, C(alkyl)2-J, —R4b, wherein R8a can also cyclize with the atom to which R8a is bonded to form a 3, 4, 5, 6 or 7-membered ring that is aromatic or non-aromatic and may contain one or more heteroatoms, wherein the ring may be further substituted one or more times with substitutents that are the same or different;
- and
- R9 is selected from the group consisting of H, alkyl and CH2CO2H.
15 more elements
A compound selected from the group consisting of:
A compound of formula VII:
- or a pharmaceutically acceptable salt thereof, including the pyridine N-oxide thereof;
- wherein
- R1 is —Z—CO2H and -A-Z—CO2H;
- R1a is hydrogen, —Z—CO2H, and -A-Z—CO2H, wherein if R1a is hydrogen, then the Z residue of R1 is substituted by at least two CO2H groups;
- or
- R1 and R1a, taken in combination, form a saturated, partially unsaturated or aromatic heterocycle having 4 to 7 ring atoms and having 0-3 additional ring heteroatoms selected from N, O and S, wherein the heterocycle is substituted by at least two residues independently selected from CO2H, —Z—CO2H, and -A-Z—CO2H;
- A is independently selected at each occurrence from the group consisting of a —C(O)—, —C(O)O—, —C(O)N(R8a)—, —S(O)2—, —S(O)—, —C(H)═N—, —S(O)2N(R8a)—, and —S(O)N(R8a)—;
- Z is C1-C10alkylene, C3-C8cycloalkylene, C3-C8heterocycloalkylene, phenylene, or 5-6 membered heteroarylene, each of which is optionally substituted with one or more groups independently selected from C1-C4alkyl, C1-C4alkoxy, hydroxy, amino, mono- and di-C1-C6alkylamino, C(O)OH, or halogen;
- R2 is hydrogen, C1-6alkyl, hydroxyC1-6alkyl, C1-6alkoxyC0-6alkyl, C3-7cycloalkylC0-4-alkyl, arylC0-4alkyl, or a residue of the formula:
- R2a is selected from the group consisting of H, substituted or unsubstituted alkyl, OH, OR4a, OC(O)R4a, OC(O)N(R8a)2 and N(R8a)2;
- R2b is selected from the group consisting of absent, H and alkyl, or R2a and R2b may together form ═O or ═NH;
- R3 an R12 are each, independently, selected from the group consisting of H, halogen, OR4b, -A-J, and N(R8a)2;
- R4a is selected from the group consisting of H, and alkyl;
- R4b is selected from the group consisting of alkyl and —(CH2—CH2—O—)n—R9, wherein n is an integer of 1-500, 1,000, 2,000, 3,000, 4,000, 5,000, 10,000, 20,000, 30,000, 40,000, 50,000, or 60,000 or is a mean of a plurality of integers having a value of 1-500, 1,000, 2,000, 3,000, 4,000, 5,000, 10,000, 20,000, 30,000, 40,000, 50,000, or 60,000;
- R5 is selected from the group consisting of H, alkyl, and R4b;
- J is selected from the group consisting of H, F, O-alkyl, N(R8a)2, N+(R8a)3, N(R8a)C(O)alkyl, CO2H, C(═O)N(R8a)2, CO2-alkyl, P(O)(OH)2, P(O)(O-alkyl)2, and a substituted nitrogen-containing heterocycle;
- R8a is absent, or selected from the group consisting of H, -(alkyl)-, -(cycloalkyl)-, C(alkyl)2-J, —R4b, wherein R8a can also cyclize with the atom to which R8a is bonded to form a 3, 4, 5, 6 or 7-membered ring that is aromatic or non-aromatic and may contain one or more heteroatoms, wherein the ring may be further substituted one or more times with substitutents that are the same or different;
- and
- R9 is selected from the group consisting of H, alkyl and CH2CO2H.
16 more elements
Dependencies are inferred from the claim text.